Inflammatory diseases in older adults: polymyalgia rheumatica

Robert Spiera1, Harry Spiera

  • 1Albert Einstein College of Medicine, New York City, NY, USA.

Geriatrics
|December 24, 2004
PubMed

Insights

Polymyalgia rheumatica (PMR) is a common inflammatory condition in older adults. Prompt diagnosis and treatment with corticosteroids are crucial for managing this reversible disease.

Area of Science:

  • Rheumatology
  • Internal Medicine
  • Geriatrics

Background:

  • Polymyalgia rheumatica (PMR) is a prevalent inflammatory disorder affecting individuals over 50, with a higher incidence in women.
  • Accurate diagnosis is essential due to the availability of effective treatments for this reversible condition.
  • PMR onset is typically acute, presenting with pain in the neck, upper arms, or pelvic girdle, sometimes accompanied by low-grade fever.

Purpose of the Study:

  • To highlight the importance of differentiating PMR from other conditions.
  • To emphasize the need for appropriate diagnostic criteria and management strategies.
  • To discuss the challenges in diagnosing PMR due to non-specific findings.

Main Methods:

  • Review of clinical presentation and diagnostic considerations for PMR.
  • Discussion of differential diagnoses for inflammatory and degenerative diseases in older adults.
  • Overview of current treatment approaches, including corticosteroid therapy.

Main Results:

  • PMR diagnosis can be challenging due to the absence of specific laboratory or radiographic markers.
  • An elevated sedimentation rate (> 50 mm/hr) is often considered a key diagnostic indicator.
  • Joint swelling is uncommon, though knee effusions may occur.

Conclusions:

  • Distinguishing PMR from other conditions is critical for effective management.
  • Treatment, primarily with prednisone, necessitates individualized regimens, especially during dose tapering.
  • Early and accurate diagnosis leads to favorable outcomes for patients with polymyalgia rheumatica.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...